Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids [NA]

View source ↗

Summary

A clinical trial is evaluating whether omega-3 fatty acids can influence risk factors for type 2 diabetes in people with normal cholesterol, focusing on insulin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 2 Diabetes, Inflammation | NA | Status: RECRUITING